ELPASBIO
Live / Applied — First extension granted (statement of use) (as of 21 Jan 2026)
What this means for you
Not registered yet, but its 10 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98742277
- Mark type
- Stylized text
- Filed
- 10 Sept 2024
- Published for opposition
- 17 Jun 2025
- Attorney of record
- Lauren Beth Emerson
Goods and services
- Class 001 — Chemicals: Excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use in the fields of arthritis, arthritis prevention, and arthritis treatment; viral vectors and plasmids for scientific research in the fields of arthritis, arthritis prevention, and arthritis treatment; biological tissue, namely, stem cells for scientific and medical research use in the fields of arthritis, arthritis prevention, and arthritis treatment
- Class 003 — Cosmetics and cleaning preparations: Cosmetics; Cosmetics consisting of herbal extracts; Herbal extracts, other than essential oils, sold as an integral component of cosmetics; Non-medicated skin care preparations; Non-medicated skin care preparations consisting of plant and exosome extracts; Cosmetic preparations for skin care; Skin soap; Cleansing milk; Shampoos; Cleaning preparations; Non-medicated bath preparations; Hair conditioners; Facial cleansers, non-medicated; Bath lotions; Beauty masks; Facial sheet masks for cosmetic use; Plant and herbal essences for cosmetic purposes; Toners for cosmetic purposes; Moisturizing creams; Anti-wrinkle creams; Skin whitening creams; Anti-freckle creams
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for medical use, namely, for the treatment and prevention of diseases, namely, arthritis; pharmaceutical preparations, namely, pharmaceutical preparations for use in the prevention and treatment of arthritis; pharmaceutical and biological preparations for medical diagnostic use in the prevention and treatment of arthritis; diagnostic kits consisting primarily of cells for medical or clinical use in the fields of arthritis, arthritis prevention, and arthritis treatment; viral vectors and plasmids for clinical use in the fields of arthritis, arthritis prevention, and arthritis treatment; cells and stem cells for medical use in the fields of arthritis, arthritis prevention, and arthritis treatment
- Class 040 — Treatment of materials: Custom manufacturing of biological tissue, blood, cells, and stem cells for use in the prevention and treatment of arthritis; custom manufacture of pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of arthritis; custom manufacture of viral vectors and plasmids for research and clinical use in the prevention and treatment of arthritis; custom manufacture of excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use in the prevention and treatment of arthritis; cryogenic preservation of tissues, cells and stem cells for use in the prevention and treatment of arthritis; freeze drying of tissues, cells and stem cells for use in the prevention and treatment of arthritis
- Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development of medicines; stem cell research services; all of the foregoing services in the fields of arthritis, arthritis prevention, and arthritis treatment
- Class 044 — Medical, beauty and agricultural services: Cell therapy services, namely, immune cell and stem cell therapy services and medical treatment using cultured cells and stem cells in the fields of arthritis, arthritis prevention, and arthritis treatment; medical services, namely, collection of biological tissue, blood, cells, and stem cells for use in the prevention and treatment of arthritis; collection and preservationof blood for use in the prevention and treatment of arthritis; providing medical information in the fields of arthritis, arthritis prevention, and arthritis treatment; providing health information in the field of arthritis and arthritis treatment; providing medical information in the field of pharmaceuticals, cell therapy, and stem cell therapy for use in the prevention and treatment of arthritis; medical treatment services, namely, medical treatment of arthritis and inflammatory diseases; medical diagnostic services in the fields of arthritis, arthritis prevention, and arthritis treatment
Owner
- Cellular Biopharma (Shanghai), Ltd., Shanghai, CN
- Cellular Biopharma (Shanghai), Ltd., Shanghai, CN
Prosecution history
- 22 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2026 — SOU EXTENSION 1 GRANTED
- 21 Jan 2026 — SOU EXTENSION 1 FILED
- 21 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2025 — NON-FINAL ACTION E-MAILED
- 18 Mar 2025 — NON-FINAL ACTION WRITTEN